R01

  • Vanderbilt University

    Researchers advance image-guided robotic surgical tools for delicate eye procedures

    Molecular, gene and cell-based therapies targeting eye diseases could prevent and potentially reverse cell degeneration that leads to loss of sight. However, delivering injections safely and accurately into targeted ocular layers remain concerns that affect the advancement of life-changing new treatments. To address the safety and reliability challenges, researchers in… Read More

    Nov. 21, 2019

  • Vanderbilt University

    NIH-funded collaboration to develop steerable robotic needles for lung biopsies

    Molecular, gene and cell-based therapies targeting eye diseases could prevent and potentially reverse cell degeneration that leads to loss of sight. However, delivering injections safely and accurately into targeted ocular layers remain concerns that affect the advancement of life-changing new treatments. To address the safety and reliability challenges, researchers in… Read More

    Nov. 8, 2017

  • Vanderbilt University

    Six profs attract National Institutes of Health grants for wide-ranging research

    Molecular, gene and cell-based therapies targeting eye diseases could prevent and potentially reverse cell degeneration that leads to loss of sight. However, delivering injections safely and accurately into targeted ocular layers remain concerns that affect the advancement of life-changing new treatments. To address the safety and reliability challenges, researchers in… Read More

    Jul. 12, 2016

  • Pietro Valdastri

    VU engineer wins $1.5 million to develop magnetic capsule endoscope

    Molecular, gene and cell-based therapies targeting eye diseases could prevent and potentially reverse cell degeneration that leads to loss of sight. However, delivering injections safely and accurately into targeted ocular layers remain concerns that affect the advancement of life-changing new treatments. To address the safety and reliability challenges, researchers in… Read More

    Sep. 22, 2014